Key result
Sphingomyelinase-treated LDLs trigger greater cytotoxicity, oxidative stress, and inflammatory responses than oxidized LDLs.
Why the study?
Since LDL sphingolipids are emerging as important regulators of atherogenesis, the study investigated the effects of sphingomyelinase on LDL properties and endothelial cell viability, apoptosis, oxidative, and inflammatory status.
Does exposure to sphingomyelinase-treated LDLs increase oxidative stress and inflammation in human umbilical vein endothelial cells compared to oxidized LDLs?
Does exposure to sphingomyelinase-treated LDLs increase oxidative stress and inflammation in human umbilical vein endothelial cells compared to oxidized LDLs?
p-value: p=<0.05
This preclinical study demonstrates that sphingomyelinase modification of LDLs potently induces endothelial inflammation, oxidative stress, and apoptosis, highlighting the potential role of LDL-derived ceramide in atherogenesis.
Low-density lipoproteins (LDLs) exert a key role in the transport of esterified cholesterol to tissues. Among the atherogenic modifications of LDLs, the oxidative modification has been mainly investigated as a major risk factor for accelerating atherogenesis. Since LDL sphingolipids are also emerging as important regulators of the atherogenic process, increasing attention is devoted to the effects of sphingomyelinase (SMase) on LDL structural and atherogenic properties. The aims of the study were to investigate the effect of SMase treatment on the physical-chemical properties of LDLs. Moreover, we evaluated cell viability, apoptosis, and oxidative and inflammatory status in human umbilical vein endothelial cells (HUVECs) treated with either ox-LDLs or SMase-treated LDLs (SMase-LDLs). Both treatments were associated with the accrual of the intracellular ROS and upregulation of the antioxidant Paraoxonase 2 (PON2), while only SMase-LDLs induced an increase of superoxide dismutase 2 (SOD2), suggesting the activation of a feedback loop to restrain the detrimental effects of ROS. The increased caspase-3 activity and reduced viability observed in cells treated with SMase-LDLs and ox-LDLs suggest a pro-apoptotic effect of these modified lipoproteins on endothelial cells. Moreover, a strong proinflammatory effect of SMase-LDLs compared to ox-LDLs was confirmed by an increased activation of NF-κB and consequent increased expression of its downstream cytokines IL-8 and IL-6 in HUVECs.
No takes yet. Share an insight, caveat, or question.
Giuliani et al. (2023) studied Endothelial dysfunction and Atherosclerosis. Sphingomyelinase-treated LDLs (SMase-LDLs) vs. Unmodified LDLs and oxidized LDLs (ox-LDLs) was evaluated on Cell viability, reactive oxygen species (ROS) levels, and inflammatory cytokine expression (p=<0.05). Sphingomyelinase-treated LDLs significantly reduced cell viability, increased intracellular ROS, and induced a stronger proinflammatory response (NF-κB activation and IL-6/IL-8 expression) compared to oxidized LDLs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: